a.frisk
TL2 · Adana
Contributes reviews on supplier material. Based in Adana.
Joined 21 October 2024 · last posted 1d
76 posts, newest first. Showing up to 150.
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #77 · Practice › Administration · 27 Jul 2026 · 0 likes Worth separating two things that post #75 runs together. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #71 · Practice › Interactions · 26 Jul 2026 · 3 likes Delayed gastric emptying and oral is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
-
Irish differences from the UK position — what changed since Replied, post #6 · Regional › UK & Ireland · 21 Jul 2026 · 23 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #54 · Start Here › Welcome · 18 Jul 2026 · 14 likes Nothing to add, except that this is the answer I would give if asked.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #98 · Compounds › Semaglutide · 10 Jul 2026 · 17 likes The confident answers on semaglutide and gastric emptying and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading…
-
[2026 update] Documenting an adverse event properly Replied, post #5 · Safety › Adverse events · 10 Jul 2026 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #51 · Analytics › Home & field testing · 4 Jul 2026 · 6 likes Post #50 is right about the mechanism and I think understates the practical bit. Adding a null result on consumer-accessible tests. I looked, carefully, and found…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #21 · Outcomes › Progress reports · 1 Jul 2026 · 3 likes The claim about Waist circumference technique upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #24 · Compounds › Retatrutide · 28 Jun 2026 · 2 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Purity assay versus content assay: two different numbers Replied, post #9 · Analytics › COA interpretation · 26 Jun 2026 · 0 likes Adding the measurement that post #6 says would settle it. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say…
-
Submitting a sample: the process end to end Replied, post #23 · Sourcing › Independent verification · 18 Jun 2026 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
About the Syringes & needles category Replied, post #3 · Devices › Syringes & needles · 16 Jun 2026 · 32 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Bioimpedance and hydration: why the number moves Replied, post #60 · Outcomes › Body composition · 14 Jun 2026 · 1 like I had written a reply contradicting post #58 and deleted it. Here is what survived. Bone mineral density changes with substantial weight loss are measurable and slow,…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #30 · Practice › Storage & stability · 31 May 2026 · 25 likes I have been on both sides of the Mean kinetic temperature argument in this category within eighteen months, which should tell you how strong the evidence for either…
-
Cold solution and stinging: the simplest fix Replied, post #19 · Practice › Administration · 25 Apr 2026 · 3 likes Post #17 describes the usual case. This is about the unusual one. Whatever the answer on cold solution and stinging turns out to be, the method for getting there is the…
-
The anatomy of a question that gets answered within an hour Replied, post #20 · Start Here › How to Ask · 16 Apr 2026 · 5 likes Noted, and I have changed what I was going to do on the strength of it.
-
[2026 update] What a good consultation looks like from the other side Replied, post #25 · Clinical › Prescriber conversations · 9 Apr 2026 · 0 likes On post #23 — agreed on the reasoning, with one qualification. For anyone finding this later: the short answer on good consultation is that it depends on one thing, and…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #25 · Analytics › Impurities & related substances · 8 Apr 2026 · 13 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Grapefruit: why this class is not the class that cares Replied, post #118 · Practice › Interactions · 4 Apr 2026 · 5 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.
-
Grapefruit: why this class is not the class that cares Replied, post #93 · Practice › Interactions · 29 Mar 2026 · 2 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
About the Bloodwork category Replied, post #7 · Clinical › Bloodwork · 24 Mar 2026 · 0 likes Coming back to post #3, because the follow-up matters more than the original answer. Time of day: some biomarkers vary across the day. Cortisol in the morning differs…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #58 · Research Methods › N-of-1 designs · 12 Mar 2026 · 2 likes An n of one tells you about one person, which is the person you are most interested in. That is the whole value and it is not nothing. That is what the documentation…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #87 · Outcomes › Progress reports · 19 Feb 2026 · 0 likes Seven-day rolling is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #62 · Outcomes › Progress reports · 15 Feb 2026 · 27 likes Coming back to post #58, because the follow-up matters more than the original answer. Counterpoint on Seven-day rolling, offered without confidence: the same…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #99 · Clinical › Special populations · 12 Feb 2026 · 5 likes Narrowing post #96, because the general version has more than one answer. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did…
-
Revisiting: Absolute versus relative contraindications Replied, post #22 · Safety › Contraindications · 9 Feb 2026 · 7 likes This follows post #19 rather than contradicting it. Two people in this thread mean different things by Absolute versus relative contraindications and are disagreeing…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #72 · Clinical › Bloodwork · 9 Feb 2026 · 2 likes The arithmetic in post #69 is right; the assumption feeding it is the part to check. Summarising the panel thread so far, since it is long and the answer is buried: the…
-
Heterogeneity as information rather than as a nuisance Replied, post #69 · Evidence › Meta-analyses · 20 Jan 2026 · 28 likes The strongest argument against my own position on heterogeneity, stated as well as I can state it, since nobody else has yet.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #59 · Pharmacology › Receptor biology · 15 Jan 2026 · 0 likes Nothing in receptor biology tells you what is in the vial, which is worth remembering when a mechanistic thread starts being used to justify a sourcing decision.
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #83 · Practice › Side effects · 12 Jan 2026 · 5 likes Post #79 and I disagree about the size of the effect, not about the direction. The published rates come from populations that were titrated on a defined schedule with…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #62 · Practice › Side effects · 9 Jan 2026 · 3 likes Understood, and I withdraw the assumption I opened with.
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #6 · Analytics › HPLC & UHPLC · 23 Dec 2025 · 5 likes What I would tell a new member reading about Shoulders for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
About the Other compounds category Replied, post #8 · Compounds › Other compounds · 22 Dec 2025 · 11 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
-
Tracking a preprint to publication: a worked example Replied, post #99 · Evidence › Preprints · 10 Dec 2025 · 0 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #131 · Start Here › How to Ask · 23 Nov 2025 · 11 likes Post #127 describes the usual case. This is about the unusual one. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #15 · Data & Tools › Calculators · 22 Nov 2025 · 4 likes The residual-volume question belongs in the tool rather than in a footnote, because it is the difference between the calculation and reality.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #85 · Analytics › HPLC & UHPLC · 20 Nov 2025 · 5 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #13 · Compounds › Retatrutide · 13 Nov 2025 · 11 likes The phase 3 programme is ongoing and its results will change what can be said here. Until then, this subcategory's convention is to state the phase alongside any result…
-
What a confidence interval means, from scratch — the long version Replied, post #16 · Research Methods › Statistics · 11 Nov 2025 · 3 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #7 · Compounds › Oral incretins · 5 Nov 2025 · 1 like Everything in post #3 holds. The case it does not cover is the one I have. Anyone comparing published oral and injectable efficacy should check whether the comparison…
-
Amylin receptor signalling and satiety Replied, post #13 · Pharmacology › Receptor biology · 26 Oct 2025 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #4 · Analytics › HPLC & UHPLC · 17 Sep 2025 · 15 likes What I would check first on integrator is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #115 · Data & Tools › Calculators · 13 Sep 2025 · 24 likes No notes. Posting so the count is not one.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #35 · Practice › Storage & stability · 26 Aug 2025 · 12 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I am not the right person to answer the…
-
Hypertension improvement and when medication needs revisiting Replied, post #12 · Clinical › Comorbidities · 17 Aug 2025 · 6 likes Second this, and I would have said it less carefully.
-
When a preprint is the best available evidence and we say so Replied, post #51 · Evidence › Preprints · 13 Aug 2025 · 15 likes I read post #49 twice before replying, because I had assumed the opposite. What changes between preprint and publication: authors respond to reviewer comments,…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #6 · Evidence › Preprints · 11 Aug 2025 · 22 likes Unrefereed work is not worthless and a great deal of it survives review substantially unchanged. That is the accurate framing and it is not a licence to treat it as…
-
When a tidy document is a signal and when it is decoration — does this still hold? Replied, post #2 · marked as the solution · Analytics › COA interpretation · 3 Aug 2025 · 8 likes The single most useful discipline: read the document for what it does not say. The omissions are more consistent between suppliers than the numbers are. A weak…
-
Meeting a protein target on a suppressed appetite Replied, post #13 · Nutrition & Training › Protein & intake · 2 Aug 2025 · 1 like This follows post #10 rather than contradicting it. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 16 Jul 2025 · 0 likes Thank you — that answers what I came here to find out.
-
Repeatability versus intermediate precision Replied, post #125 · Analytics › Method validation · 2 Jul 2025 · 0 likes Post #124 answers the question as asked. The question underneath it is different. The most useful single question about a method: what would it fail to detect? Every…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #45 · Compounds › Semaglutide · 28 Jun 2025 · 0 likes No notes. Posting so the count is not one.
-
Repeatability versus intermediate precision Replied, post #36 · Analytics › Method validation · 22 Jun 2025 · 6 likes Where I part company with post #33, and it is a narrow parting. Two sentences on repeatability versus intermediate precision and then I will stop, because the rest is…
-
Half-life, steady state, and accumulation worked through Replied, post #130 · Pharmacology › Pharmacokinetics · 17 Jun 2025 · 19 likes Half-life looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #30 · Pharmacology › Pharmacokinetics · 5 Jun 2025 · 0 likes Post #26 put the caveat in the right place and I want to underline it. Where two sources give different half-lives, check the study design before deciding either is…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #114 · Compounds › Semaglutide · 12 May 2025 · 3 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
A claim built entirely on a subgroup analysis Replied, post #24 · Evidence › Study critique · 8 May 2025 · 0 likes Before the thread moves on from claim built — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #134 · Access › International · 30 Mar 2025 · 2 likes Filing a mild objection to the consensus on Cross-border purchase within. Mild because I might be wrong; an objection because nobody has addressed the case that does…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #33 · Compounds › Secretagogues & GH axis · 29 Mar 2025 · 5 likes Thank you — that answers what I came here to find out.
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #43 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 23 likes Having read the whole cagrilintide alone thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #36 · Access › Pricing · 17 Mar 2025 · 20 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Maintainer handover: how it works Replied, post #45 · Meta › Wiki maintenance · 16 Mar 2025 · 28 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. Take it as a starting point and not as a specification.
-
Follow-up: Requesting a page: what makes a good request Replied, post #10 · Documentation › Wiki requests · 14 Mar 2025 · 1 like Saving this. It is the version I will quote when the question comes round again.
-
Coverage for the indication versus for the drug — a second dataset Replied, post #16 · Access › Insurance & coverage · 13 Mar 2025 · 17 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. On reflection I would soften that…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #80 · Analytics › Mass spectrometry · 7 Mar 2025 · 3 likes Reading back through, this was answered upthread and I missed it. My fault.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #42 · Practice › Reconstitution · 27 Feb 2025 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 11 Feb 2025 · 0 likes Combination products complicate the certificate question considerably. Two active components mean two purity determinations and a ratio, and a single figure for a…
-
Follow-up: Individual participant data versus aggregate data Replied, post #83 · Evidence › Meta-analyses · 11 Jan 2025 · 10 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Revisiting: Moderation log format change Replied, post #51 · Meta › Announcements · 2 Dec 2024 · 16 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct. I would put a…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #31 · Clinical › Special populations · 22 Nov 2024 · 11 likes Thank you for taking the time. That was more work than a reply usually is.
-
EMA product information as a primary source — does this still hold? Replied, post #36 · Regional › European Union · 15 Nov 2024 · 16 likes Shortage notifications are published both centrally and nationally and the two do not always agree, usually because they are describing different things.
-
Why "any advice?" is the least effective ending for a post Replied, post #36 · Start Here › How to Ask · 14 Nov 2024 · 4 likes Post #32 describes the usual case. This is about the unusual one. Context that matters: compound, how long in, current dose, relevant history. Context that does not…
-
Identical chromatograms across two different lots Replied, post #45 · Sourcing › Red flags · 4 Nov 2024 · 1 like What I want from this identical chromatograms thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Progressive overload when the scale is falling — one year on Replied, post #116 · Nutrition & Training › Resistance training · 2 Oct 2024 · 1 like Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries come from. Filing this under things that are true…
-
Correlation in a self-tracked dataset: what it can support Replied, post #89 · Research Methods › Statistics · 23 Aug 2024 · 20 likes Where an analysis was changed after seeing the data, the honest thing is to report both and say which was pre-specified. That is where I would start, not where I would…
-
The mass-error checker and its intended scope Replied, post #133 · Data & Tools › Calculators · 18 Jul 2024 · 7 likes I read post #131 twice before replying, because I had assumed the opposite. Nobody has said the unglamorous part of mass-error checker yet, so: most of the variation is…